GlassScriptPhysician profile
Katherine S Masterpol
NPI 1154596096
$5,464.69
in general payments reported to CMS, 2019-2025
25 companies · $1,042 in 2025
The $1,042 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,108 · 2020: $521 · 2021: $1,015 · 2022: $481 · 2023: $638 · 2024: $659 · 2025: $1,042.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,059 · Education: $280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,059.14 |
| Education | $279.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $1,116.06 | 2019-2025 | Nemluvio, Aklief |
| Janssen Biotech, INC. | $907.31 | 2019-2024 | Tremfya |
| Abbvie INC. | $673.92 | 2019-2025 | |
| Ucb, INC. | $385.82 | 2019-2025 | Bimzelx |
| Leo Pharma INC. | $343.94 | 2019-2020 | |
| Pfizer INC. | $300.52 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $293.74 | 2019-2022 | |
| Dermavant Sciences, INC. | $256.50 | 2023-2024 | Vtama |
| Lilly USA, LLC | $239.11 | 2020-2025 | Ebglyss, Olumiant |
| Genzyme Corporation | $217.88 | 2023-2025 | |
| Janssen Scientific Affairs, LLC | $124.16 | 2019 | |
| Allergan, INC. | $122.02 | 2019-2022 | |
| Organon LLC | $109.41 | 2025 | Vtama |
| Sun Pharmaceutical Industries INC. | $101.73 | 2022-2024 | Winlevi, Absorica Ld |
| Henry Schein, INC. | $36.63 | 2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Botanix Sb INC | $36.03 | 2025 | Sofdra |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $34.93 | 2024-2025 | |
| Amgen INC. | $26.46 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $25.82 | 2024 | Sotyktu |
| Organogenesis INC. | $24.99 | 2023 | Puraply |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $21.65 | 2025 | Jublia, Cabtreo |
| Biofrontera INC. | $21.11 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $16.35 | 2020 | |
| Strata Skin Sciences, INC. | $15.50 | 2023 | Xtrac |
| Prugen, INC. Pharmaceuticals | $13.10 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Masterpol listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.